Clinical Trials in San Antonio

Showing 2201-2220 of 7,028 trials

Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

NCT05349617

The purpose of this phase 3, randomized, double-blind, placebo-controlled study is to evaluate the safety and immunogenicity to PXVX0317 in adults ≥65 years of age.

Chikungunya Virus

Bavarian Nordic413 participantsStarted May 2022

Miami, Florida, United States • Miami Lakes, Florida, United States • St. Petersburg, Florida, United States +7 more locations

TERMINATEDPhase 3< 1 mile

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

NCT02612311

This study evaluates the combination of ublituximab, a novel monoclonal antibody, and TGR-1202, a novel PI3K delta inhibitor compared to obinutuzumab and chlorambucil, and compared to ublituximab or TGR-1202 alone in Chronic Lymphocytic Leukemia (CLL) participants.

Chronic Lymphocytic Leukemia

TG Therapeutics, Inc.603 participantsStarted Nov 2015

Huntsville, Alabama, United States • Mobile, Alabama, United States • Chandler, Arizona, United States +151 more locations

Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

Find Trials by Condition in San Antonio

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

Urinary Catheter Self-Discontinuation After Urogynecology Surgery

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration

Osia 2 Pediatric Expansion Study

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

Study of ATH434 in Participants with Multiple System Atrophy

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease